IP Library › Granted Patent US 11,104,881
Granted Patent B2
US 11,104,881 · App. 15/954,983 · Granted Aug 31, 2021

Method for highly efficient conversion of human stem cells to lineage-specific neurons

Inventors: Mingyao Ying (Ellicott City, MD); John Laterra (Baltimore, MD)
Assignee: The Johns Hopkins University
C12N5/0619A61K35/30C12N15/85C12N15/86C12N2500/38C12N2501/01C12N2501/115C12N2501/119C12N2501/13C12N2501/15C12N2501/41C12N2501/60C12N2506/02C12N2506/08C12N2506/45C12N2510/00C12N2533/32C12N2533/52C12N2740/15043C12N2799/027
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,104,881
App. No.
15/954,983
Granted
Aug 31, 2021
Kind
B2
Abstract

The present invention relates to the field of stem cells. More specifically, the present invention provides methods and compositions useful for the highly efficient conversion of human stem cells to lineage-specific neurons. In a specific embodiment, a method of inducing differentiation of human stem cells into dopaminergic (DA) neurons comprises the steps of (a) transfecting human stem cells with a lentiviral vector encoding Atoh1, wherein the vector is Dox inducible; and (b) growing the transfected cells in culture in the presence of Dox, Sonic Hedgehog (SHH) and FGF-8b until DA neurons are induced.

Claims (8)

1. A method of inducing differentiation of human stem cells into dopaminergic (DA) neurons comprising the steps of:

a. transfecting human stem cells with an Atoh1 messenger ribonucleic acid (mRNA); and

b. growing the transfected cells in culture in the presence of Dox, Sonic Hedgehog (SHH) and FGF-8b until DA neurons are induced.

2. The method of claim 1 , wherein the human stem cells are induced pluripotent stem cells (iPSCs).

3. The method of claim 1 , wherein the human stem cells are embryonic stem cells (ESCs).

4. The method of claim 2 , wherein the human stem cells are neural stem cells (NSCs).

5. The method of claim 1 , wherein prior to step (b), the method further comprises the step of transfecting the human stem cells a NeuroD1 mRNA.

6. The method of claim 5 , wherein prior to step (b), the method further comprises the step of transfecting the human stem cells with a Neurogenin 2 mRNA.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 17, 2021
From: YING, MINGYAO; LATERRA, JOHN
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 056576/0432 →
Continuity (3)
Division 15100682
Provisional Application 61911238 · Dec 3, 2013
Related Publication 20180305663A1 · Oct 25, 2018
Cited By (1)
US 12,668,813